Patient and health care delays in large (class T3–T4) oral, oropharyngeal, and laryngeal carcinomas
|Author:||Atula, Markus1; Aro, Katri1; Irjala, Heikki2;|
1Department of Otorhinolaryngology – Head and Neck Surgery, Helsinki University Hospital, University of Helsinki, Helsinki, Finland
2Department of Otorhinolaryngology – Head and Neck Surgery, Turku University Hospital, University of Turku, Turku, Finland
3Department of Otorhinolaryngology – Head and Neck Surgery, Tampere University Hospital, University of Tampere, Tampere, Finland
4Department of Otorhinolaryngology – Head and Neck Surgery, Kuopio University Hospital, University of Eastern Finland, Kuopio, Finland
5Department of Otorhinolaryngology – Head and Neck Surgery, Oulu University Hospital, University of Oulu, Oulu, Finland
6Department of Oral and Maxillofacial Surgery, Helsinki University Hospital, University of Helsinki, Helsinki, Finland
7Department of Clinical Sciences, Intervention and Technology, Division of Ear, Nose and Throat Diseases, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
8Faculty of Medicine, Research Program in Systems Oncology, University of Helsinki, Helsinki, Finland
|Persistent link:|| http://urn.fi/urn:nbn:fi-fe20231003138546
John Wiley & Sons,
|Publish Date:|| 2024-03-07
Background: Head and neck cancers (HNCs) are often diagnosed at an advanced stage. We investigated the lengths and factors associated with patient, primary health care (PHC), and specialist care (SC) delays in T3–T4 oral, oropharyngeal, and laryngeal cancer.
Methods: A nationwide prospective questionnaire-based study (n = 203) with the 3-year long data collection period.
Results: The median patient, PHC and SC delays were 58, 13, and 43 days, respectively. Lower level of education, heavy alcohol use, hoarseness, difficulties breathing, and eventual palliative treatment associated with a longer patient delay. A lump on the neck or facial swelling associated with a shorter PHC delay. Conversely, if symptoms were treated as an infection, PHC delay was longer. The treatment modality and tumor site affected SC delay.
Conclusions: Patient delay stands as the most notable factor contributing to delays before treatment. HNC symptom awareness thus remains especially important among HNC risk groups.
Head & neck
|Pages:||1215 - 1225|
|Type of Publication:||
A1 Journal article – refereed
|Field of Science:||
3126 Surgery, anesthesiology, intensive care, radiology
Helsinki and Uusimaa Hospital District Research Funding; Ida Montinin Säätiö, Grant/Award Number: 20210333; Sigrid Juséliuksen Säätiö, Grant/Award Number: 8073; Suomalais-Norjalainen Lääketieteen Säätiö, Grant/Award Number: 2021058; Suomen Lääketieteen Säätiö, Grant/Award Number: 4290.
© 2023 Wiley Periodicals LLC. This is the peer reviewed version of the following article: Atula, M, Aro, K, Irjala, H, et al. Patient and health care delays in large (class T3–T4) oral, oropharyngeal, and laryngeal carcinomas. Head & Neck. 2023; 45(5): 1215-1225, which has been published in final form at https://doi.org/10.1002/hed.27335. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. This article may not be enhanced, enriched or otherwise transformed into a derivative work, without express permission from Wiley or by statutory rights under applicable legislation. Copyright notices must not be removed, obscured or modified. The article must be linked to Wiley’s version of record on Wiley Online Library and any embedding, framing or otherwise making available the article or pages thereof by third parties from platforms, services and websites other than Wiley Online Library must be prohibited.